Author

Aakash Patel

Observed name: Aakash R. Patel

Institution: Moffitt Cancer Center

Observed institutions: Rutgers, The State University of New Jersey, National Institutes of Health, Children's National, McGill University Health Centre, Moffitt Cancer Center, Medical University of the Americas, National Institute of Allergy and Infectious Diseases, Rutgers Cancer Institute, Research Institute of the McGill University Health Centre, Vaccine Research Center, University of Maryland, College Park

ORCID: 0000-0002-1846-8862

Observed ORCID: 0000-0002-1846-8862

OpenAlex ID: A5070449110

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

2020 · Li Ou, Wing-Pui Kong, et al. · Scientific Reports · 48

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial

2019 · Inés Colmegna, Mariana L Useche, et al. · The Lancet Rheumatology · 35

Drug release kinetics of temperature sensitive liposomes measured at high-temporal resolution with a millifluidic device

2017 · Caitlin Burke, Matthew R. Dreher, et al. · International Journal of Hyperthermia · 26

Harnessing AI and Gut Microbiome Research for Precision Health

2024 · Ritcha Saxena, Vikas Sharma, et al. · Journal of Artificial Intelligence General science (JAIGS) · 22

Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial

2019 · Janna R. Shapiro, Breanna Hodgins, et al. · Vaccine · 19

Advances in purification of SARS-CoV-2 spike ectodomain protein using high-throughput screening and non-affinity methods

2022 · Nicole Cibelli, Gabriel Arias, et al. · Scientific Reports · 14

Molecular Landscape and Therapeutic Strategies against Colorectal Cancer

2024 · Aakash Patel, Pat Gulhati · Cancers · 12

Immune Checkpoint Inhibitors in the Management of Urothelial Carcinoma

2021 · Aakash Patel, Daniel I. Bisno, et al. · Journal of Cancer Immunology · 5

Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development

2022 · Deepika Gollapudi, Erwin Rosales‐Zavala, et al. · Biotechnology Progress · 3

A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable – A proof of concept study

2018 · Alexander I. Makarkov, Aakash R. Patel, et al. · Vaccine · 3

How Artificial Intelligence(ai) Can Help Tackle Covid-19 - an Analysis

2020 · Associate Consultant, Bristlecone, Mumbai, India., Amey Patil, et al. · International Journal of Advanced Research · 2

Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C

2021 · Cindy X. Cai, Nicole A. Schneck, et al. · Journal of the American Society for Mass Spectrometry · 1

Novel virtual pilot consultation program with intake medical oncologist to rapidly evaluate patients with metastatic gastrointestinal (GI) cancers.

2025 · Adrianna Oraiqat, Richard Levine, et al. · JCO Oncology Practice

Development and application of an analytical approach to assess an antibody's potential for disulfide reduction

2021 · Yanhong Yang, Niutish Bastani, et al. · Biotechnology Progress

Author response for "Development and Application of an Analytical Approach to Assess an Antibody's Potential for Disulfide Reduction"

2021 · Yanhong Yang, Niutish Bastani, et al.

Works count: 15

Citation count: 190

H-index: 7

I10-index: 7